ConductScience.org, home

Paper39197864

Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action.

Peres MFP and 9 others. Cephalalgia, 2024. Cited by 59 papers, by iCite.

Cite this record

ConductScience Library. Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action. Papers, record 39197864. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39197864

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action.
PubMed
Journal
Cephalalgia
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
59
iCite
Relative citation ratio, by iCite
15.38, provisional
iCite
Revised in PubMed
2026-05-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Peres MFPMario Fernando Prietohttps://orcid.org/0000-0002-0068-1905
2Sacco SSimona
3Pozo-Rosich PPatriciahttps://orcid.org/0000-0003-0796-4702
4Tassorelli CCristinahttps://orcid.org/0000-0003-1513-2113
5Ahmed FFayyaz
6Burstein RRamihttps://orcid.org/0000-0003-3763-8916
7Ashina SSaithttps://orcid.org/0000-0003-3973-6640
8Uluduz DDerya
9Husøy AKAndreas Kattem
10Steiner TJTimothy J

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Migraine DisordersMajor topic
StrokeMajor topic
Adolescent
Adult
Child
Humans
Global Burden of Disease

Source PubMed

Download CSV of topics

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.

PMIDTitleJournalYearIn PapersSource
42931331Patient-Reported Adherence, Knowledge and Perceived Outcomes After Specialist Nursing Education in a Multidisciplinary Headache Unit: A Cross-Sectional Observational Study.Nurs Rep2026https://conductscience.org/library/papers/42931331PubMed
42920904Migraine burden inequities and 2050 projections in Africa based on global burden of disease 2023.iScience2026https://conductscience.org/library/papers/42920904PubMed
42866175Fremanezumab for episodic migraine in children and adolescents: the evolving landscape of CGRP-targeted therapies.Transl Pediatr2026https://conductscience.org/library/papers/42866175PubMed
42769685Metaverse-Related and Immersive Digital Technologies in Neurorehabilitation: A Scoping Review.Arch Rehabil Res Clin Transl2026https://conductscience.org/library/papers/42769685PubMed
42761667Analysis of Sleep Quality and Its Associated Factors in Adolescents with Migraine.J Pain Res2026https://conductscience.org/library/papers/42761667PubMed
42743099Exploring Proximal and Distal Ultrasound-Guided Greater Occipital Nerve Block Approaches in Migraine: A Systematic Review and Meta-Analysis.Pain Pract2026https://conductscience.org/library/papers/42743099PubMed
42726340Meaningful Measurable Quality Outcomes in Headache Management.Curr Pain Headache Rep2026https://conductscience.org/library/papers/42726340PubMed
42634802Changes in P2X4 receptor expression following AbobotulinumtoxinA treatment in patients with chronic migraine: A case series study.Curr J Neurol2025https://conductscience.org/library/papers/42634802PubMed
42572641Evaluation of Ocular Higher-Order Aberrations in Patients with Migraine: A Comparative Study.Rom J Ophthalmol2026https://conductscience.org/library/papers/42572641PubMed
42465667Adapting to life with chronic migraine: a qualitative study of lived experiences among multi-ethnic Asian patients.Front Pain Res (Lausanne)2026https://conductscience.org/library/papers/42465667PubMed
42356280Integrating Nutrition and Physical Activity into the EXEMIG/01 Interdisciplinary Model for Chronic and High-Frequency Migraine.Nutrients2026https://conductscience.org/library/papers/42356280PubMed
42348808Clinical Differentiation of Self-Limited Epilepsy With Autonomic Seizures (Panayiotopoulos Syndrome) and Childhood Migraine.Neurol Clin Pract2026https://conductscience.org/library/papers/42348808PubMed
42256516The Social Life of Migraine: A Meta-Ethnography of Lived Experience in Adults With Migraine.Health Serv Insights2026https://conductscience.org/library/papers/42256516PubMed
42185562Quality by design based development and optimization of a thermoreversible in situ intranasal gel of zavegepant for nose to brain delivery in migraine therapy.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42185562PubMed
42158933What's Needed for a Migraine Cost-Of-Illness Study in Aotearoa New Zealand: Review of Data Sources and Gaps.J R Soc N Z2026https://conductscience.org/library/papers/42158933PubMed
42118419Addressing the Treatment Gap for Pediatric Headache in Underserved Regions.Curr Pain Headache Rep2026https://conductscience.org/library/papers/42118419PubMed
42067810Real-world effectiveness of onabotulinumtoxinA as first-line treatment in chronic migraine and sequential transition to anti-CGRP monoclonal antibodies: a retrospective multicenter study.BMC Neurol2026https://conductscience.org/library/papers/42067810PubMed
42057934A study on cortical habituation based on event-related potential P50 and CNV.Front Neurol2026https://conductscience.org/library/papers/42057934PubMed
41996064Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial.Pain Ther2026https://conductscience.org/library/papers/41996064PubMed
41987076Genome-wide association analysis of treatment response to onabotulinumtoxinA in Han Chinese patients with chronic migraine: a pilot study.BMC Neurol2026https://conductscience.org/library/papers/41987076PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39197864

GET https://conductscience.org/api/papers/v1/39197864/cited_by?page=2